NPI Details
PCR-DX, LLC is a clinical medical laboratory in Birmingham, AL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. PCR-DX, LLC NPI is 1265042592. The provider is registered as an organization entity type and is a single specialty group.
The provider's business location address is:
2112 11TH AVE S STE 110
BIRMINGHAM, AL
ZIP 35205-843
Phone: (205) 882-5227
The provider's authorized official is Robert Lilly .
The authorized official title is Cfo and has the following contact phone number (205) 706-7727.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
- Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
- Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
- Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
- Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
- Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
The enumeration date for this NPI number is 8/2/2020 and was last updated on 4/30/2025.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207SM0001X | Medical Genetics | Molecular Genetic Pathology | | | No |
| 2 | 291U00000X | Clinical Medical Laboratory | | | | Yes |
